GLP-1 receptor agonists

Diabetes drugs cut Alzheimer's risk

Diabetes drugs cut Alzheimer’s risk by nearly half

A comprehensive analysis reveals that specific diabetes treatments could significantly reduce dementia risk, potentially transforming prevention strategies for millions. The connection between metabolic health and